Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2024

Open Access 01-12-2024 | Cytostatic Therapy | Research

A preliminary, quantitative study on the use of traditional and complementary medicine by cancer patients seen at the Senkatana oncology clinic, Maseru, Lesotho

Authors: Mopa A. Sooro, Thabo S. Thoahlane, Maseabata V. Ramathebane, Kabelo A. Mputsoe

Published in: BMC Complementary Medicine and Therapies | Issue 1/2024

Login to get access

Abstract

Background

The use of traditional and complementary medicine (TCM) by cancer patients remains common in several countries especially in the Sub-Saharan Africa. However, the reasons for use are complex and change with time and geographic location, they may vary from therapy to therapy, and they are different from one individual to another. The use of TCM has been associated with active coping behaviour and a way through which patients take control of their own health. However, cancer patients do not disclose their use of TCM to the attending healthcare professionals and therefore the effects of these medicines on the patients may not be ascertained.

Aim

To investigate the use of traditional and complementary medicines among patients diagnosed with cancer.

Methods

A cross-sectional, quantitative study was conducted at Senkatana Oncology clinic in May to June 2023. Cancer patients underwent standardized, quantitative interviews using structured questionnaires about their use of TCM. Descriptive statistics were used to analyse the data. Logistic regression analysis was also used to identify factors associated with satisfaction with the performance of TCM.

Results

All interviewed patients (n = 50, 100%) reported to be using TCM. Patients consisted of 24 females (48%) and 26 males (52%) in the age range 14 to 82 years old. The majority of the study population was in the age group 35–44 years old. The most prevalent cancer among participating males was prostate cancer and among females was cervical cancer. Biological products use was the most prominent with the highest average percentage usage (14.7%). The majority of patients (66%, n = 33) indicated that they just wanted to try everything that could help. Patients (n = 47, 94%) further reported that they had been using complementary medicine during the same period as they were using conventional treatment so that both may work to help each other. Neither gender nor age predicted satisfaction with the performance of traditional and complementary medicine.

Conclusions

It is concluded that all interviewed cancer patients use TCM. Patients indicated that one of the reasons for using TCM was that they wanted to try everything that could help in their cancer care. Patients further reported that they did not inform their oncologist of their concurrent use of TCM because they had been advised not to use other medicines besides what they are given at the clinic.
Appendix
Available only for authorised users
Literature
6.
go back to reference World Health Organisation. Global Cancer Observatory (GLOBOCAN), Lesotho. 2020. World Health Organisation. Global Cancer Observatory (GLOBOCAN), Lesotho. 2020.
8.
go back to reference Mwaka AD, Abbo C, Kinengyere AA. Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-saharan Africa: a scoping review on the use, safety and risks. Cancer Manage Res. 2020;3699–712. https://doi.org/10.2147/CMAR.S251975. Mwaka AD, Abbo C, Kinengyere AA. Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-saharan Africa: a scoping review on the use, safety and risks. Cancer Manage Res. 2020;3699–712. https://​doi.​org/​10.​2147/​CMAR.​S251975.
10.
go back to reference World Health Organization., 2017. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization; 2002. World Health Organization., 2017. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization; 2002.
14.
go back to reference Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, Asampong E. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMC Complement Altern Med. 2013;13(1):1–9.CrossRef Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, Asampong E. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMC Complement Altern Med. 2013;13(1):1–9.CrossRef
16.
go back to reference Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005;104(1). https://doi.org/10.1002/cncr.21107. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005;104(1). https://​doi.​org/​10.​1002/​cncr.​21107.
18.
go back to reference Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer: Interdisciplinary Int J Am Cancer Soc. 2000;89(4):873–80.CrossRef Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer: Interdisciplinary Int J Am Cancer Soc. 2000;89(4):873–80.CrossRef
20.
go back to reference Chen Z, Xu L, Shi W, Zeng F, Zhuo R, Hao X, Fan P. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017. Breast Cancer Res Treat. 2020;180:481–90.CrossRefPubMed Chen Z, Xu L, Shi W, Zeng F, Zhuo R, Hao X, Fan P. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017. Breast Cancer Res Treat. 2020;180:481–90.CrossRefPubMed
Metadata
Title
A preliminary, quantitative study on the use of traditional and complementary medicine by cancer patients seen at the Senkatana oncology clinic, Maseru, Lesotho
Authors
Mopa A. Sooro
Thabo S. Thoahlane
Maseabata V. Ramathebane
Kabelo A. Mputsoe
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2024
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-024-04388-3

Other articles of this Issue 1/2024

BMC Complementary Medicine and Therapies 1/2024 Go to the issue